Shenzhen Manweizhi Technology Co., Ltd – Trademark Portfolio

Entity Type: 99

Shenzhen Manweizhi Technology Co., Ltd holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include MEWEACHI. The owner is based in Shenzhen City.

New World, Haishan St, Yantian Dist

1501, Bldg C, Phase III, Yishan Garden

Shenzhen City 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MEWEACHI
MEWEACHI
Registered 2024

Trademark Classifications

Shenzhen Manweizhi Technology Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Shenzhen Manweizhi Technology Co., Ltd have?

Shenzhen Manweizhi Technology Co., Ltd has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Shenzhen Manweizhi Technology Co., Ltd file in?

Shenzhen Manweizhi Technology Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 3 (Cosmetics & Cleaning). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Shenzhen Manweizhi Technology Co., Ltd's most well-known trademarks?

Shenzhen Manweizhi Technology Co., Ltd's registered trademark portfolio includes well-known marks such as MEWEACHI. These are among 1 currently registered trademark in the portfolio.

What is Shenzhen Manweizhi Technology Co., Ltd's trademark registration success rate?

Shenzhen Manweizhi Technology Co., Ltd has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.